Integrated microfluidic platform with MEMS cantilever for the early detection of prostate cancer using dry mass sensing
Integrated microfluidic platform with MEMS cantilever for the early detection of prostate cancer using dry mass sensing
批准号:
EP/R00403X/1
负责人:
Jerome Charmet
金额:
$12.88万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2017
资助国家:
英国
项目状态:
已结题
起止时间:
2017 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer is the most prevalent cancer in men. In the UK alone, more than 40'000 cases are diagnosed every year (www.nhs.uk). The current accepted clinical gold standard for the diagnosis of prostate cancer is the measure of the prostate-specific antigen (PSA) levels in blood. However, it is now accepted that PSA test are unreliable and can lead to over-diagnosis. These false-positive results mean that many men are subjected to invasive and painful biopsies for no reason. Our pro-ject aims to address these limitations through the development of a minimally invasive, low-cost biosensing platform to detect PCA3, a promising urinary diagnosis biomarker for prostate cancer. In order to provide a viable alternative to ultra-sensitive, yet more complex and time-consuming assays, our platform should be capable of detecting, within 15 minutes, PCA3 down to concentra-tions of 1 ng/mL in urine. This goal will be achieved through the implementation of a simple and novel concept to enable high-resolution measurement, using ultra-sensitive mechanical sensors integrated in microfluidic devices. The concept of measurement air pockets, proposed here for the first time, will permit the capture of the analyte molecules in the liquid phase and their measurement in the gas phase; through the introduction of air pockets as measurement chambers. The measurement of liquid borne analytes in air will minimize viscous damping losses and thereby enable high-resolution, high-sensitivity measurement. In order to facilitate the deployment of the platform in clinical settings, we will test it using clinical samples from the early development stage and we will ensure that it can be fabricated using ac-cepted manufacturing methods. After a proof-of-principle device has been demonstrated we will seek further funding, in collaboration with prostate cancer clinicians, to evaluate the platform in clin-ical settings. It is noted that the platform could be adapted for the diagnosis of other conditions and that the simple concept proposed here could be applied to other sensor for a range of applications including environmental monitoring and food safety.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3390/mi11020135
发表时间:
2020-02-01
期刊:
MICROMACHINES
影响因子:
3.4
作者:
[Charmet, Jerome, Rodrigues, Rui, Whulanza, Yudan]
通讯作者:
Whulanza, Yudan
Low-Cost Microfabrication Tool Box.
低成本微加工工具箱。
DOI:
10.17863/cam.51414
发表时间:
2020
期刊:
影响因子:
--
作者:
[Charmet J]
通讯作者:
Charmet J
DOI:
10.1007/s10404-020-02402-x
发表时间:
2021-01
期刊:
Microfluidics and Nanofluidics
影响因子:
2.8
作者:
[Atakan Atay;Alper Topuz;Büşra Sarıarslan;E. Yıldırım;J. Charmet;K. Couling;B. Çetin]
通讯作者:
Atakan Atay;Alper Topuz;Büşra Sarıarslan;E. Yıldırım;J. Charmet;K. Couling;B. Çetin
DOI:
10.1063/1.5145109
发表时间:
2020-04-13
期刊:
APPLIED PHYSICS LETTERS
影响因子:
4
作者:
[Kartanas, T., Toprakcioglu, Z., Knowles, T. P. J.]
通讯作者:
Knowles, T. P. J.
DOI:
10.3389/fmolb.2021.651232
发表时间:
2021
期刊:
Frontiers in molecular biosciences
影响因子:
5
作者:
[Bungon T, Haslam C, Damiati S, O'Driscoll B, Whitley T, Davey P, Siligardi G, Charmet J, Awan SA]
通讯作者:
Awan SA
共 6 条
国内基金
海外基金
基于压力敏感肾单位微流控芯片的肾上皮细胞CAT1-mTOR通路在梗阻性肾损伤中的作用机制研究
-
批准号:82370678
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:林厚维
-
依托单位:
基于RPA-microfluidic chip技术高效诊断侵袭性真菌病的研究
-
批准号:2020A151501763
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2020
-
负责人:马庆林
-
依托单位:
利用Microfluidic系统研究血流速度对巨核细胞生成血小板的信号调控机制
-
批准号:81770131
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2017
-
负责人:戴菁
-
依托单位: